Capital One Financial Begins Coverage on Olema Pharmaceuticals (NASDAQ:OLMA)

Capital One Financial started coverage on shares of Olema Pharmaceuticals (NASDAQ:OLMA – Get Rating) in a research note released on Friday, The Fly reports. The firm issued an overweight rating and a $16.00 target price on the stock. A number of other equities analysts have also recently weighed in on OLMA. Lifesci Capital reissued an […]

Related Keywords

Monaco , ,Tudor Investment Corp Et Al ,Olema Pharmaceuticals Inc ,Olema Pharmaceuticals Trading Down ,Russell Investments Group Ltd ,Credit Suisse Group ,News Ratings For Olema Pharmaceuticals Daily ,Prelude Capital Management ,Olema Pharmaceuticals ,Hedge Funds Weigh In On Olema Pharmaceuticals ,Analyst Recommendations For Olema Pharmaceuticals ,Capital One Financial ,Get Rating ,Suisse Group ,Pharmaceuticals Trading Down ,Capital Management ,Asset Management ,Investments Group ,Olema Pharmaceuticals Daily ,Nasdaq Olma ,Dolma ,Medical ,Initiated Coverage ,Capital One Financial Co ,